Home › Dyax Corp. Announces Expansion Of Phase 1b Clinical Trial For DX-2930
 

Keywords :   


Dyax Corp. Announces Expansion Of Phase 1b Clinical Trial For DX-2930

2014-11-05 07:17:01| drugdiscoveryonline Home Page

Dyax Corp. recently announced the expansion of its ongoing Phase 1b clinical trial evaluating DX-2930 to include additional patients and dosing cohorts

Tags: trial phase corp clinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Delayed implementation of EID eartag rule requested
More »